Skip to main content
logo
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.53
-0.53 (-8.75%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Champions Oncology Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Revenue
59.4359.4356.9450.1653.8749.11
Revenue Growth
4.36%4.36%13.54%-6.90%9.70%19.66%
Gross Profit
28.5328.5328.5620.7524.3425.48
Operating Income
-1.14-1.144.55-7.36-5.260.61
Net Income
-0.44-1.184.7-7.28-5.340.55
Earnings Per Share
-0.08-0.080.33-0.54-0.390.04
EPS Growth
-----100.00%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Cash & Investments
4.874.879.792.6210.129.01
Total Debt
4.514.516.117.438.69.47
Net Cash (Debt)
0.360.363.68-4.811.52-0.46
Net Cash Growth
--90.22%----
Net Cash Per Share
0.030.030.26-0.360.11-0.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Operating Cash Flow
-4.47-4.477.39-6.143.976.5
Capital Expenditures
-0.56-0.56-0.39-0.84-2.87-2.38
Free Cash Flow
-5.04-5.047-6.971.14.11
Free Cash Flow Growth
-----73.26%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Gross Margin
48.00%48.00%50.15%41.38%45.18%51.88%
Operating Margin
-1.92%-1.92%8.00%-14.67%-9.76%1.24%
Pretax Margin
-1.56%-1.56%8.12%-14.57%-9.78%1.19%
Profit Margin
-1.98%-1.98%8.26%-14.51%-9.90%1.12%
FCF Margin
-8.47%-8.47%12.29%-13.90%2.04%8.38%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
PE Ratio
--21.67--192.00
Forward PE
-114.60119.1764.1043.8142.95
P/FCF Ratio
--14.08-60.5825.25
PS Ratio
1.291.391.731.311.242.11